Jee H Jung Selected Research

Jee H Jung Research Topics

Disease

20	Neoplasms (Cancer) 07/2021 - 01/2004
7	Breast Neoplasms (Breast Cancer) 01/2016 - 01/2012
6	Inflammation (Inflammations) 07/2021 - 01/2004
6	Carcinoma (Carcinomatosis) 10/2013 - 12/2007
5	Leukemia 11/2018 - 05/2004
2	Asthma (Bronchial Asthma) 11/2018 - 02/2016
2	Prostatic Neoplasms (Prostate Cancer) 12/2014 - 05/2011
2	Ovarian Neoplasms (Ovarian Cancer) 12/2012 - 08/2010
1	Weight Gain 03/2022
1	Obesity 03/2022
1	Neuroblastoma 07/2021
1	Wounds and Injuries (Trauma) 09/2020
1	Cushing Syndrome 01/2018
1	Parkinson Disease (Parkinson's Disease) 04/2017
1	Edema (Dropsy) 01/2017
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Glioma (Gliomas) 02/2016
1	Acute Kidney Injury (Acute Renal Failure) 01/2016
1	Colitis 10/2015
1	Respiratory Insufficiency (Respiratory Failure) 07/2015
1	Bacterial Infections (Bacterial Infection) 12/2014
1	Diabetes Complications 10/2013
1	Atopic Dermatitis (Atopic Eczema) 01/2013
1	Crohn Disease (Crohn's Disease) 01/2013
1	Hepatocellular Carcinoma (Hepatoma) 02/2012
1	Alzheimer Disease (Alzheimer's Disease) 01/2010

Drug/Important Bio-Agent (IBA)

5	Histone Deacetylase InhibitorsIBA 12/2012 - 01/2008
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2022 - 10/2015
3	SirtuinsIBA 01/2016 - 09/2012
3	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2015 - 01/2014
3	Antineoplastic Agents (Antineoplastics)IBA 12/2014 - 05/2004
3	methyl jasmonateIBA 01/2013 - 09/2010
3	Histone Deacetylases (Histone Deacetylase)IBA 12/2012 - 01/2008
3	dideoxypetrosynol AIBA 01/2007 - 12/2004
2	LigandsIBA 03/2022 - 01/2018
2	viriditoxinIBA 08/2020 - 12/2014
2	TubulinIBA 08/2020 - 12/2014
2	OvalbuminIBA 11/2018 - 02/2016
2	CytokinesIBA 11/2018 - 01/2011
2	ResveratrolIBA 01/2017 - 01/2014
2	jasmonic acid (jasmonate)IBA 10/2015 - 01/2013
2	psammaplin AIBA 02/2015 - 01/2008
2	Cytochalasin BIBA 10/2013 - 05/2012
2	Tamoxifen FDA LinkGeneric 10/2012 - 01/2012
2	N1- hydroxy- N8- (4- phenoxyphenyl)octanediamideIBA 10/2012 - 08/2010
2	CaspasesIBA 02/2012 - 07/2005
2	FlavonoidsIBA 05/2011 - 01/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2011 - 12/2003
2	AcidsIBA 12/2008 - 01/2007
2	cynaropicrinIBA 05/2004 - 01/2004
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2022
1	Rosiglitazone (Avandia)FDA Link 03/2022
1	cyclo-(L-Pro-L-Phe)IBA 07/2021
1	S-NitrosoglutathioneIBA 09/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2020
1	HydrogelsIBA 09/2020
1	Poloxamer (Poloxamer 407)IBA 09/2020
1	AlginatesIBA 09/2020
1	Antimitotic AgentsIBA 08/2020
1	MucinsIBA 11/2018
1	isoindoline-1,3-dioneIBA 11/2018
1	Mifepristone (RU 486)FDA Link 01/2018
1	SteroidsIBA 01/2018
1	Monoamine Oxidase (MAO)IBA 04/2017
1	CarrageenanIBA 01/2017
1	Therapeutic UsesIBA 01/2017
1	4-(6-hydroxy-2-naphthyl)-1,3-benzenediolIBA 01/2017
1	Anti-Allergic Agents (Antiallergic Agents)IBA 02/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	2-hydroxyethyl 5-chloro-4,5-didehydrojasmonateIBA 10/2015
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 07/2015
1	Biological ProductsIBA 02/2015
1	Proteins (Proteins, Gene)FDA Link 12/2014
1	anthraceneIBA 01/2014
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2014
1	fucosterolIBA 10/2013
1	Aldehyde Reductase (Aldose Reductase)IBA 10/2013
1	ChemokinesIBA 01/2013
1	Chemokine CCL22IBA 01/2013
1	apicidinIBA 12/2012
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 10/2012
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 10/2012
1	Sirtuin 1IBA 09/2012
1	sirtinolIBA 09/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2012
1	Estrogen ReceptorsIBA 01/2012
1	MHY336IBA 05/2011
1	Topoisomerase II InhibitorsIBA 05/2011
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 05/2011
1	Peptides (Polypeptides)IBA 02/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2011
1	methyl 5-chloro-4,5-didehydrojasmonateIBA 09/2010
1	Hydroxamic Acids (Hydroxamic Acid)IBA 08/2010
1	Vorinostat FDA Link 08/2010

Therapy/Procedure

5	Therapeutics 08/2020 - 02/2011
1	Intraperitoneal Injections 01/2017
1	Drug Therapy (Chemotherapy) 08/2010
1	Aftercare (After-Treatment) 08/2010